Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Relay Therapeutics Receives Notice Of Termination From Genentech For Collaboration And License Agreement; Relay Received $121.8M From Genentech, Including $75M Upfront And $45M In Milestones

Author: Benzinga Newsdesk | July 16, 2024 04:19pm

Effective In 180 Days; Agreement Involved Development Of Migoprotafib (GDC-1971); No Further Payments Or Obligations After Termination Date

Posted In: RLAY